EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast

Authors

Xiuning Le
Eric Nadler
Daniel B Costa
John Victor Heymach

Publication Date

11-1-2023

Journal

Target Oncology

DOI

10.1007/s11523-023-00994-2

PMID

37792237

PMCID

PMC10663258

PubMedCentral® Posted Date

10-4-2023

PubMedCentral® Full Text Version

Post-print

Abstract

See the video and supplementary file.

Keywords

Humans, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Tyrosine Kinase Inhibitors, Protein Kinase Inhibitors, ErbB Receptors, Mutation

Comments

This article has been corrected. See Target Oncol. 2023 Oct 27;18(6):991. This article has been corrected. See Target Oncol. 2023 Dec 9;19(1):125.

Published Open-Access

yes

Recommended Citation

Le, Xiuning; Nadler, Eric; Costa, Daniel B; et al., "EGFR Tyrosine Kinase Inhibitors for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Podcast" (2023). Faculty, Staff and Student Publications. 3319.
https://digitalcommons.library.tmc.edu/uthgsbs_docs/3319